Laboratorios Farmaceuticos Rovi S A : ROVI releases the 2020 Annual Corporate Governance Report

THIS TRANSLATION IS FOR INFORMATION PURPOSES ONLY.

IN THE EVENT OF ANY DISCREPANCY BETWEEN THE SPANISH VERSION AND THE ENGLISH

VERSION, THE SPANISH VERSION SHALL PREVAIL.

ISSUER IDENTIFICATION

Year-end date:

31/12/2020

Tax identification No (C.I.F.):

Company name:

A-28041283

LABORATORIOS FARMACEUTICOS ROVI, S.A.

Registered address:

JULIAN CAMARILLO, 35, MADRID

A. CAPITAL STRUCTURE

A.1.

Complete the table below with details of the share capital of the company:

Date of last change	Share capital (€)	Number of shares	Number of voting rights
18/10/2018	3,364,137.90	56,068,965	56,068,965

Please state whether there are different classes of shares with different associated rights:

[ ]

[ √ ]

Yes No

A.2.

Please provide details of the company's significant direct and indirect shareholders at year end, excluding any directors:

Name of shareholder	% of shares carrying voting rights	% of voting rights through financial instruments	% of total voting rights
Direct	Indirect	Direct	Indirect
WELLINGTON MANAGEMENT GROUP, LLP	0.00	4.92	0.00	0.00	4.92
T.ROWE PRICE ASSOCIATES, INC.	0.00	3.00	0.00	0.00	3.00
NORBEL INVERSIONES, S.L.	63.11	0.00	0.00	0.00	63.11
INDUMENTA PUERI, S.L.	0.00	5.06	0.00	0.00	5.06

The data have been taken from the official records of the National Securities Market Commission (CNMV).

Breakdown of the indirect holding:

Name of indirect shareholder	Name of direct shareholder	% of shares carrying voting rights	% of voting rights through financial instruments	% of total voting rights
WELLINGTON MANAGEMENT GROUP, LLP	DIVERSAS I.I.C.	4.92	0.00	4.92
T.ROWE PRICE ASSOCIATES, INC.	T. ROWE PRICE INTERNATIONAL FUNDS	3.00	0.00	3.00

Name of indirect shareholder	Name of direct shareholder	% of shares carrying voting rights	% of voting rights through financial instruments	% of total voting rights
INDUMENTA PUERI, S.L.	GLOBAL PORTFOLIO INVESTMENTS S.L.	5.06	0.00	5.06

State the most significant shareholder structure changes during the year:

T. Rowe Price International Discovery Fund - a separate series within T. Rowe Price International Funds, Inc. whose funds are managed by T. Rowe Price Associates, Inc. and T. Rowe Price International Ltd. dropped below 3% of share capital on 14/12/2020.

The data have been taken from the official records of the National Securities Market Commission (CNMV).

A.3.

In the following tables, list the members of the Board of Directors (hereinafter "directors") with voting rights in the company:

% of shares carrying voting	% of voting rights through	% of voting rights that can be transmitted through financial instruments
Name of director	rights	financial instruments	% of total voting rights
Direct	Indirect	Direct	Indirect	Direct	Indirect
No data

% of voting rights that can be

Total percentage of voting rights held by the Board of Directors

0.00

Breakdown of the indirect holding:

Name of director	Name of direct shareholder	% of shares carrying voting rights	% of voting rights through financial instruments	% of total voting rights	% of voting rights that can be transmitted through financial instruments
No data

A.4.

If applicable, state any family, commercial, contractual or corporate relationships that exist among significant shareholders to the extent that they are known to the company, unless they are insignificant or arise in the ordinary course of business, except those that are reported in Section A.6:

Name of related party	Nature of relationship	Brief description
No data

A.5.

If applicable, state any commercial, contractual or corporate relationships that exist between significant shareholders and the company and/or group, unless they are insignificant or arise in the ordinary course of business:

Name of related party	Nature of relationship	Brief description
No data

A.6.

Describe the relationships, unless insignificant for the two parties, that exist between significant shareholders or shareholders represented on the Board and directors, or their representatives in case of proprietary directors.

Explain, as the case may be, how the significant shareholders are represented. Specifically, state those directors appointed to represent significant shareholders, those whose appointment was proposed by significant shareholders and/or companies in its group or those tied to significant shareholders and/or companies in its group, specifying the nature of such relationships or ties. In particular, mention the existence, identity and post of directors, or their representatives, as the case may be, of the listed company, who are, in turn, members of the Board of Directors or their representatives of companies that hold significant shareholdings in the listed company or in group companies of these significant shareholders:

Name or company name of related director or representative	Name or company name of related significant shareholder	Company name of the group company of the significant shareholder	Description of relationship/post
MR JUAN LÓPEZ-BELMONTE LÓPEZ	NORBEL INVERSIONES, S.L.	NORBEL INVERSIONES, S.L.	Chairman & shareholder